We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Tapinarof is an investigational therapeutic aryl hydrocarbon receptor modulating agent (TAMA) which has been evaluated as a topical therapy in multiple Phase I and Phase II studies involving over 800 human subjects.